Clinical Trials Logo
  1. Home
  2. Helicobacter Pylori Infection
  3. NCT05065138

Comparison of Helicobacter Pylori Eradication Effect Before and After Training of Gastroenterologists

Helicobacter Pylori Infection Clinical Trial

Official title:
Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists on Standardized Helicobacter Pylori Eradication Therapy

Clinical Trial Summary

The researchers recruited gastroenterologists. Physician subjects recruited Helicobacter pylori-positive patients before and after receiving standardized training on Helicobacter pylori eradication. There are no restrictions on treatment options and drugs during the trial. Compare the eradication rate, adverse reaction rate, and patient compliance before and after physician training.

Clinical Trial Description

The researchers recruited no less than 20 gastroenterologists to participate in the study, and gastroenterologists recruited 25 patients who were over 18 years of age and were positive for Helicobacter pylori for the first time. In this process, the patient population is not restricted, and the eradication program is not restricted. Gastroenterologists followed up their diagnosis and treatment. Researchers track and record patients' medications and adverse reactions during medication via phone or WeChat to assess patient compliance. Record the eradication rate. We will provide standardized Helicobacter pylori eradication training for the Department of Gastroenterology after all patients treated by gastroenterologists have been eradicated and reviewed. After the training, the gastroenterologist recruited 25 patients who were over 18 years old and were newly treated with Helicobacter pylori positive. In this process, the patient population is not restricted, and the eradication program is not restricted. Gastroenterologists followed up their diagnosis and treatment. Researchers track and record patients' medications and adverse reactions during medication via phone or WeChat to assess patient compliance. Record the eradication rate. Compare the eradication rate, adverse reaction rate and compliance of patients before and after the training of gastroenterologists. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05065138
Study type Interventional
Source Shandong University
Contact Xiuli Zuo, MD, PhD
Phone 86 15588818685
Email zuoxiuli@sdu.edu.cn
Status Recruiting
Phase N/A
Start date September 22, 2021
Completion date September 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05061732 - Helicobacter Pylori Eradication and Follow-up Phase 4
Completed NCT03779074 - Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies Phase 3
Completed NCT06076681 - A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules Phase 1/Phase 2
Recruiting NCT05329636 - Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy Phase 1/Phase 2
Completed NCT05049902 - Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication Phase 4
Not yet recruiting NCT06200779 - Tailored vs. Empirical Helicobacter Pylori Infection Treatment Phase 4
Not yet recruiting NCT06037122 - Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication
Completed NCT04617613 - Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait Phase 4
Withdrawn NCT02552641 - Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole Phase 4
Completed NCT02873247 - Standardize Communication With General Practitioner & Patient for Improved Eradication of Helicobacter Pylori
Completed NCT02557932 - Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication Phase 3
Recruiting NCT02249546 - Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection Phase 4
Completed NCT01933659 - Anti-H. Pylori Effect of Deep See Water Phase 3
Unknown status NCT01464060 - 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication Phase 4
Completed NCT00841490 - Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults N/A
Recruiting NCT05549115 - Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection N/A
Recruiting NCT05728424 - One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL Phase 3
Recruiting NCT05997433 - Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori（SHARE2302) N/A
Completed NCT04708405 - The Relationship Between Helicobacter Pylori Infection and Inflammatory Bowel Diseases: A Real-life Observation
Not yet recruiting NCT05493644 - A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure